International Business Machines Corporation IBM ← Back to all reports

International Business Machines Corporation

IBM · Technology
B ★★★ Hold
Jul 26, 2026 · Score 75 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $214.19
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $205.00 ($195.00–$215.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $246.80
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+15.2%

Type A - International Business Machines Corporation (IBM) 20260726 Stock Analysis

📅 IBM Key Upcoming Events

🏢 Step 1: IBM Company Overview & Business Model

Q1-A1. What is IBM?

Q1-A2. How Does IBM Make Money?

Q1-A3. IBM’s Revenue Segments & Core Income Sources

Q1-A4. Who Are IBM’s Competitors?

Q1-A5. IBM Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: IBM’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does IBM Have a Durable Economic Moat?

Q2-A2. Is IBM’s Growth Sustainable?

Q2-A3. How Does IBM Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is IBM Profitable? Financial Health Analysis

Q3-A2. How Profitable Is IBM? (Margins & ROIC)

Q3-A3. What Drives IBM’s Returns? (ROIC Breakdown)

Q3-A4. Are IBM’s Earnings High Quality?

Q3-A5. Is IBM’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: IBM Forensic Accounting & Dilution Review

Q4-A1. Does IBM Have Accounting Red Flags?

Q4-A2. Is IBM Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is IBM’s Cash Flow?

Q4-A4. Is IBM Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: IBM Management & Shareholder Alignment

Q5-A1. Can You Trust IBM’s Management? (Guidance Track Record)

Q5-A2. What Are IBM Insiders Doing?

Q5-A3. Is IBM’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: IBM Market Flow & Sentiment

Q6-A1. Analyst Consensus vs IBM Guidance

Q6-A2. What Is IBM’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: IBM Catalysts & Price Triggers

Q7-A1. What Could Move IBM Stock? (Top 3 Catalysts)

Q7-A2. IBM’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is IBM Fairly Valued? Valuation Analysis

Q8-A1. IBM’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. IBM vs Peers: Valuation Comparison

Q8-A3. Is IBM Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into IBM? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. IBM’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of IBM? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to IBM?

Q9-A2. How Sensitive Is IBM to the Economy?

Q9-A3. IBM Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: IBM Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy IBM? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. IBM’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is IBM’s Disastrous 42% Plunge in Q2 Mainframe Revenue a Structural Extinction Event or a Predictable Cyclical Trough?

Q2: Can IBM’s 16x Forward P/E Be Justified by the Electrification Supercycle and Hybrid Cloud Transition?

Q3: Will the Aggressive Monetization of Confluent and HashiCorp Destroy IBM’s Developer Goodwill?

Q4: Does IBM’s Strategy to Expand Quantum Computing via HRL Laboratories Present Tangible Value?

Q5: Is the $12.5B Generative AI Book of Business Merely Unbilled Consulting Labor?

Q6: Can the $5 Billion Lightwell Initiative Successfully Monetize Open-Source Vulnerabilities?

Q7: Does the $62 Billion Debt Load Cripple IBM’s Ability to Fund Future M&A?

Q8: Will Arvind Krishna’s Credibility Recover Before the End of 2026?

Q9: Can the Confluent Acquisition Truly Deliver an “Agentic AI” Ecosystem?

Q10: Is IBM’s Turnaround Permanently Anchored by Its Low-Margin Consulting Division?

International Business Machines Corporation (IBM)

Rating History

  1. 2026-07-02 B 80
  2. 2026-07-26 B 75